| TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination J Zhang, MM Hu, YY Wang, HB Shu Journal of Biological Chemistry 287 (34), 28646-28655, 2012 | 382 | 2012 |
| RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms Y Qin, MT Zhou, MM Hu, YH Hu, J Zhang, L Guo, B Zhong, HB Shu PLoS Pathog 10 (9), e1004358, 2014 | 197 | 2014 |
| Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1 CQ Lei, B Zhong, Y Zhang, J Zhang, S Wang, HB Shu Immunity 33 (6), 878-889, 2010 | 176 | 2010 |
| VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361 (6399), 290-295, 2018 | 145 | 2018 |
| Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase X Zheng, B Zhai, P Koivunen, SJ Shin, G Lu, J Liu, C Geisen, ... Genes & development 28 (13), 1429-1444, 2014 | 137 | 2014 |
| TRIM38 inhibits TNFα-and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3 MM Hu, Q Yang, J Zhang, SM Liu, Y Zhang, H Lin, ZF Huang, YY Wang, ... Proceedings of the National Academy of Sciences 111 (4), 1509-1514, 2014 | 131 | 2014 |
| Using seahorse machine to measure OCR and ECAR in cancer cells J Zhang, Q Zhang Cancer Metabolism: Methods and Protocols, 353-363, 2019 | 124 | 2019 |
| VHL and hypoxia signaling: beyond HIF in cancer J Zhang, Q Zhang Biomedicines 6 (1), 35, 2018 | 114 | 2018 |
| MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma ST Bailey, AM Smith, J Kardos, SE Wobker, HL Wilson, B Krishnan, ... Nature communications 8 (1), 15770, 2017 | 82 | 2017 |
| Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response Y Ran, J Zhang, LL Liu, ZY Pan, Y Nie, HY Zhang, YY Wang Journal of molecular cell biology 8 (1), 31-43, 2016 | 81 | 2016 |
| Transmembrane Protein 214 (TMEM214) mediates endoplasmic reticulum stress-induced caspase 4 enzyme activation and apoptosis C Li, J Wei, Y Li, X He, Q Zhou, J Yan, J Zhang, Y Liu, Y Liu, HB Shu Journal of Biological Chemistry 288 (24), 17908-17917, 2013 | 69 | 2013 |
| EglN2 associates with the NRF 1‐PGC 1α complex and controls mitochondrial function in breast cancer J Zhang, C Wang, X Chen, M Takada, C Fan, X Zheng, H Wen, Y Liu, ... The EMBO journal 34 (23), 2953-2970, 2015 | 66 | 2015 |
| The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor-and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein … H Zheng, Q Li, R Chen, J Zhang, Y Ran, X He, S Li, HB Shu Journal of Biological Chemistry 288 (2), 819-825, 2013 | 55 | 2013 |
| RAVER1 is a coactivator of MDA5-mediated cellular antiviral response H Chen, Y Li, J Zhang, Y Ran, J Wei, Y Yang, HB Shu Journal of molecular cell biology 5 (2), 111-119, 2013 | 41 | 2013 |
| Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer G Zurlo, X Liu, M Takada, C Fan, JM Simon, TS Ptacek, J Rodriguez, ... Nature communications 10 (1), 5177, 2019 | 33 | 2019 |
| Death-associated protein kinase 1 is an IRF3/7-interacting protein that is involved in the cellular antiviral immune response. J Zhang, MM Hu, HB Shu, S Li Cell Mol Immunol, 2014 | 32 | 2014 |
| EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor M Takada, M Zhuang, H Inuzuka, J Zhang, G Zurlo, J Zhang, Q Zhang Oncotarget 8 (4), 6787, 2017 | 19 | 2017 |
| TET2 suppresses VHL deficiency-driven clear cell renal cell carcinoma by inhibiting HIF signaling X Zhang, S Li, J He, Y Jin, R Zhang, W Dong, M Lin, Y Yang, T Tian, ... Cancer research 82 (11), 2097-2109, 2022 | 15 | 2022 |
| FDXR drives primary and endocrine-resistant tumor cell growth in ER+ breast cancer via CPT1A-mediated fatty acid oxidation C Yan, R Gao, C Gao, K Hong, M Cheng, X Liu, Q Zhang, J Zhang Frontiers in Oncology 13, 1105117, 2023 | 6 | 2023 |
| EglN2 Positively Regulates Mitochondrial Function in Breast Cancer J Zhang, X Zheng, Q Zhang Molecular & Cellular Oncology, 2015 | 5 | 2015 |
hongbing shuWuhan University在 whu.edu.cn 的电子邮件经过验证
hongbing shuWuhan University在 whu.edu.cn 的电子邮件经过验证
Qing ZhangUT SOUTHWESTERN Medical Center在 utsouthwestern.edu 的电子邮件经过验证